Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne/Becker muscular dystrophies: Part I: rationale
- 31 October 2002
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 12, S49-S51
- https://doi.org/10.1016/s0960-8966(02)00082-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The fate of individual myoblasts after transplantation into muscles of DMD patientsNature Medicine, 1997
- 4. Gene Therapy of Duchenne Muscular DystrophyAdvances in Genetics, 1997
- Gene therapy in Duchenne muscular dystrophyBrain & Development, 1996
- Myoblast Transfer in the Treatment of Duchenne's Muscular DystrophyNew England Journal of Medicine, 1995
- Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular DystrophyCell Transplantation, 1993
- Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based geneHuman Genetics, 1991
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991
- The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point MutationScience, 1989
- The complete sequence of dystrophin predicts a rod-shaped cytoskeletal proteinCell, 1988
- Dystrophin: The protein product of the duchenne muscular dystrophy locusCell, 1987